7,033 Shares in CorVel Corp. $CRVL Purchased by EntryPoint Capital LLC

Key Points

• EntryPoint Capital LLC acquired 7,033 shares of CorVel Corp. (NASDAQ: CRVL) in the first quarter, valued at approximately $787,000, making it the firm's 16th largest position.
• CorVel reported earnings of $0.52 per share for the last quarter, with a return on equity of 32.31% and a net margin of 10.98%.
• Insider trading activity included Director Alan Hoops selling 3,000 shares for about $339,150, reflecting a 15.24% decrease in his position.

EntryPoint Capital LLC purchased a new position in CorVel Corp. (NASDAQ:CRVL - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 7,033 shares of the business services provider's stock, valued at approximately $787,000. CorVel makes up 0.4% of EntryPoint Capital LLC's investment portfolio, making the stock its 16th biggest position.

Other institutional investors have also recently bought and sold shares of the company. Meeder Asset Management Inc. purchased a new position in CorVel in the 1st quarter worth about $25,000. LGT Financial Advisors LLC increased its stake in CorVel by 200.0% in the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider's stock worth $28,000 after purchasing an additional 170 shares in the last quarter. von Borstel & Associates Inc. purchased a new position in CorVel in the 1st quarter worth about $28,000. Allworth Financial LP increased its stake in CorVel by 4,000.0% in the 1st quarter. Allworth Financial LP now owns 574 shares of the business services provider's stock worth $64,000 after purchasing an additional 560 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in CorVel by 58.6% in the 1st quarter. GAMMA Investing LLC now owns 685 shares of the business services provider's stock worth $77,000 after purchasing an additional 253 shares in the last quarter. Hedge funds and other institutional investors own 51.36% of the company's stock.

CorVel Trading Up 0.8%

Shares of CRVL opened at $89.51 on Wednesday. The business's 50-day moving average price is $95.98 and its 200 day moving average price is $106.40. The stock has a market capitalization of $4.59 billion, a P/E ratio of 46.14 and a beta of 0.95. CorVel Corp. has a 1-year low of $85.13 and a 1-year high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last released its earnings results on Tuesday, August 5th. The business services provider reported $0.52 earnings per share for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.

Insider Activity at CorVel

In other CorVel news, Director Alan Hoops sold 3,000 shares of CorVel stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $113.05, for a total transaction of $339,150.00. Following the transaction, the director owned 16,688 shares of the company's stock, valued at $1,886,578.40. The trade was a 15.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director R Judd Jessup sold 935 shares of CorVel stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $113.50, for a total value of $106,122.50. Following the transaction, the director directly owned 129,519 shares in the company, valued at approximately $14,700,406.50. This trade represents a 0.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,079 shares of company stock worth $1,446,023. Company insiders own 44.56% of the company's stock.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.